A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
Clinical trial NCT03582033 · TERMINATED
Trial details
- NCT number
- NCT03582033
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2023-11-09
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.